These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2276203)

  • 1. Effect of heparin in nonionic contrast media on blood coagulation and its dose response curve.
    Hwang MH; Piao ZE; Sheu SH
    Cathet Cardiovasc Diagn; 1990 Dec; 21(4):275-7. PubMed ID: 2276203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of heparin-supplemented iopamidol on the blood coagulation].
    Kawai J; Miyazawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Oct; 56(12):874-6. PubMed ID: 8940819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin supplementation of nonionic contrast agents.
    Massee DR; Smith DC; Westengard JC; Bull BS
    J Vasc Interv Radiol; 1991 May; 2(2):209-13. PubMed ID: 1799759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of contrast media under systemic heparinization on blood coagulation and fibrinolytic system during angiocardiography--comparison of ionic and nonionic contrast media].
    Himi K; Takemoto A; Himi S; Kamata R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Aug; 52(8):1139-47. PubMed ID: 1408685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin pharmacokinetics and in vitro anticoagulant activity in patients receiving nonionic radiographic contrast media.
    Becker RC; Clyne C; Weiner BH; Lew R; Ball SP; Corrao JM; Haugh L; Tracy R; Bovill EG
    Cardiology; 1991; 79(1):31-8. PubMed ID: 1777912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and partial thromboplastin time: an international survey.
    Poller L; Thomson JM; Yee KF
    Br J Haematol; 1980 Jan; 44(1):161-5. PubMed ID: 7378288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of iodinated contrast media on blood clotting.
    Corot C; Perrin JM; Belleville J; Amiel M; Eloy R
    Invest Radiol; 1989 May; 24(5):390-3. PubMed ID: 2745021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].
    Vukusich A; Avalos C; Orellana G; Cifuentes C; Rivas J; Calderón F
    Rev Med Chil; 1995 Jun; 123(6):735-41. PubMed ID: 8525227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell aggregation versus blood clot formation in ionic and nonionic contrast media.
    Kimball JP; Sansone VJ; Diters LA; Wissel PS
    Invest Radiol; 1988 Nov; 23 Suppl 2():S334-9. PubMed ID: 3198376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin neutralising activity of whole blood in patients undergoing vascular surgery.
    Harbourne T; Nicolaides AN; Golcman L; Shiffrin E
    J Cardiovasc Surg (Torino); 1987; 28(1):22-5. PubMed ID: 3805107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of thromboembolism during diagnostic and interventional cardiac procedures with nonionic contrast media.
    Hwang MH; Piao ZE; Murdock DK; Messmore HL; Giardina JJ; Scanlon PJ
    Radiology; 1990 Feb; 174(2):453-7. PubMed ID: 2296654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects.
    Carr ME; Carr SL
    Thromb Res; 1994 Sep; 75(6):617-30. PubMed ID: 7831681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of in vitro interaction between heparin and nitroglycerin.
    Barnes AD; Horn JR; Wittkowsky AK
    Am J Clin Pathol; 1996 Mar; 105(3):298-300. PubMed ID: 8602610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy.
    Holmes MB; Schneider DJ; Hayes MG; Sobel BE; Mann KG
    Circulation; 2000 Oct; 102(17):2051-7. PubMed ID: 11044419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new route of heparin administration--the lung.
    Kavanagh LW; Jaques LB
    Arzneimittelforschung; 1976; 26(3):389-92. PubMed ID: 989334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
    Despotis GJ; Hogue CW; Santoro SA; Joist JH; Barnes PW; Lappas DG
    Crit Care Med; 1995 Oct; 23(10):1674-9. PubMed ID: 7587232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionic and non-ionic contrast media interaction with anticoagulant drugs.
    Parvez Z; Moncada R; Messmore HL; Fareed J
    Acta Radiol Diagn (Stockh); 1982; 23(4):401-4. PubMed ID: 7158402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.